In The Lancet, Friedrich Koehler and colleagues report the results of a large trial of home telemonitoring for heart failure (Telemedical Interventional Management in Heart Failure II [TIM-HF2]),1 which showed that remote patient management for 12 months reduced the proportion of days lost due to unplanned cardiovascular hospital admissions or all-cause mortality (the primary endpoint) compared with usual care (4·88% [95% CI 4·55–5·23] for patients assigned to remote patient management vs 6·64% [6·19–7·13] for those assigned to usual care; ratio 0·80 [95% CI 0·65–1·00]; p=0·0460).
Original Article: [Comment] Telehealth: delivering high-quality care for heart failure